Williamette Valley Cancer Institute and Research Center

Eugene, Oregon 97401

1 studies enrolling now · 4 studies all time

What they study most

Fallopian Tube Cancer, Metastatic Castration Resistant Prostate Cancer (mCRPC), Metastatic Pancreatic Cancer, Platinum-resistant Ovarian Cancer, Primary Peritoneal Cancer, Urinary Bladder Neoplasms, Urothelial Cancer

Studies at this site

• Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309) — Recruiting now
• ProSTAR: A Study Evaluating CPI-1205 in Patients With Metastatic Castration Resistant Prostate Cancer — Completed
• Phase 3 Study of Nemvaleukin Alfa in Combination With Pembrolizumab in Patients With Platinum-Resistant Epithelial Ovarian Cancer (ARTISTRY-7) — Stopped early
• Study of Effect of Azeliragon in Patients Refractory to Prior Treatment of Metastatic Pancreatic Cancer — Status unconfirmed